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Transporter expressionThe metabolic disorder glutaric aciduria type 1 (GA1) is caused by deﬁciency of the mitochondrial glutaryl-
CoA dehydrogenase (GCDH), leading to accumulation of the pathologic metabolites glutaric acid (GA) and
3-hydroxyglutaric acid (3OHGA) in blood, urine and tissues. Affected patients are prone to metabolic crises
developing during catabolic conditions, with an irreversible destruction of striatal neurons and a subse-
quent dystonic–dyskinetic movement disorder. The pathogenetic mechanisms mediated by GA and 3OHGA
have not been fully characterized. Recently, we have shown that GA and 3OHGA are translocated throughmem-
branes via sodium-dependent dicarboxylate cotransporter (NaC) 3, and organic anion transporters (OATs) 1 and
4. Here, we show that induced metabolic crises in Gcdh−/− mice lead to an altered renal expression pattern of
NaC3 and OATs, and the subsequent intracellular GA and 3OHGA accumulation. Furthermore, OAT1 transporters
aremislocalized to the apicalmembraneduringmetabolic crises accompanied by a pronounced thinning of prox-
imal tubule brush border membranes. Moreover, mitochondrial swelling and increased excretion of low molec-
ular weight proteins indicate functional tubulopathy. As the data clearly demonstrate renal proximal tubule
alterations in this GA1 mouse model during induced metabolic crises, we propose careful evaluation of renal
function in GA1 patients, particularly during acute crises. Further studies are needed to investigate if these ﬁnd-
ings can be conﬁrmed in humans, especially in the long-term outcome of affected patients.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Glutaric aciduria type 1 (GA1) is an autosomal-recessively inherited
inborn error in the degradative pathway of the amino acids lysine,
hydroxylysine and tryptophan, caused by deﬁciency of themitochondrial
matrix enzyme glutaryl-CoA dehydrogenase (GCDH). GCDH deﬁciency
leads to the accumulation of the pathologic metabolites glutaric (GA)
and 3-hydroxyglutaric (3OHGA) acids in tissues and body ﬂuids. Affectedtype 1; GABA, γ-aminobutyric
in diet; HNF, hepatocyte nuclear
ent dicarboxylate cotransporter;
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053.
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rights reserved.patients are prone to the development of metabolic crises precipitated by
catabolic states during a time window of vulnerability between 6 and
36 months of age, with an irreversible destruction of striatal neurons
and a subsequent dystonic–dyskinetic movement disorder. The symp-
tomatic treatment consists of an adequate emergency management dur-
ing catabolic situations, a lysine-restricted diet and supplementation of
carnitine to promote the coupling and urinary excretion of GA and
3OHGA [1,2].
The pathomechanisms leading to neurodegeneration in GA1 are un-
known. GA- and 3OHGA-mediated activation of N-methyl-D-aspartate
(NMDA) receptors, the inhibition of synthesis of the neurotransmitter
γ-aminobutyric acid (GABA), the impairment of mitochondrial energy
production, and the disintegration of endothelial barriers have been
reported in various in vitro and in vivomodels [3–7].
AGCDH-deﬁcientmousemodel displays the biochemical hallmarks of
theGA1disease [8], and the administration of a highprotein diet (HPD) to
4-week-old [9] or 6-week-old [10] Gcdh−/− mice leads to the develop-
ment of metabolic crises with a further increase of GA and 3OHGA con-
centrations in tissues and urine.
Several members of the dicarboxylate transporter family have
been identiﬁed to mediate the translocation of GA and 3OHGA
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the metabolites GA and 3OHGA is facilitated by the concerted action
of the sodium-dependent dicarboxylate co-transporter 3 (NaC3, Slc13a3)
and the organic anion transporter (OAT) 1 (Slc22a6) at the basolateral
site, and OAT4 (Slc22a11) at the apical membrane, of GCDH-expressing
renal proximal tubule cells [13]. Almost no data, however, are available
on the expression and regulation of these transporters in kidney cells of
Gcdh−/− mice during HPD-induced metabolic crises, and the conse-
quences of acute HPD-induced crises on the morphology and function
of the kidney. A single GA1 patient with an early onset of neurologic dis-
ease, accompanied by a congenital nephrotic syndrome with acute glo-
merulonephritis, rapidly progressive renal failure and death has been
described [14]. Interestingly, Gcdh−/− mice under basal conditions dis-
play a signiﬁcant enlargement of kidneys [8] and during HPD-induced
metabolic crises an accumulation of 3OHGA in kidney cells [10,11].
In the present study, we investigated the mRNA expression of NaC3,
Oat1, Oat2 (Slc22a7, the murine equivalent of human OAT4), the organic
anion transporting polypeptide (Oatp) 1a6 (Slc21a13), and the renal-
speciﬁc transporter (Rst, Slc22a12), the murine ortholog of the human
urate transporter URAT1, as well as the protein expression and immuno-
histochemical distribution of OAT1. Furthermore, we performed ultra-
structural analyses of mouse kidneys as well as functional investigations
ofmouse urine, both under basal conditions and during inducedmetabol-
ic crises.
Here we show that during induced metabolic crises, the mRNA ex-
pression of Oat1 and Oat2 is increased and decreased, respectively,
which likely contributes to the intracellular accumulation of pathologic
metabolites in the kidney of Gcdh−/−mice previously reported [10]. Fur-
thermore, we demonstrate that the metabolic crises result in an increase
of OAT1 protein and its mislocalization from the basolateral to the apical
membrane, accompanied by loss of proximal tubule brush border mem-
branes, and ultrastructural changes of mitochondria in renal proximal tu-
bule cells. Beyond that, during induced metabolic crises the pattern of
proteins excreted into urine by Gcdh−/− mice indicates the presence of
tubulopathy.
2. Materials and methods
2.1. Mice
Gcdh−/−mice andwild-type littermate controls were generated from
heterozygotes [8]. The genetic background of all mice groups used in this
study was C57BL6/SJ129 hybrid. The genotypes were conﬁrmed by poly-
merase chain reaction (PCR) andmeasurements of glutarylcarnitine con-
centration in dried blood spots. The mice were housed in an animal
facility of theUniversityHospitalwith a12-h light–dark cycle andallowed
water and food ad libitum. Animal care was provided in accordance with
institutional guidelines. Anesthetized mice were used for preparation of
kidneys, perfused for electron microscopy or immunohistochemistry as
described below. Special mice food with high protein content (70% ca-
sein) was purchased from Harlan Laboratories (Indianapolis, IN, USA).
Mice were fed with this special diet until they displayed symptoms of
an induced metabolic crisis [9]. Urine was collected in metabolic cages
3600M009 from Tecniplast (Hohenpeißenberg, Germany).
2.2. Antibodies and reagents
Polyclonal anti-organic anion transporter 1 antibody raised in rab-
bits was from Alpha Diagnostic International (San Antonio, TX, USA),
polyclonal anti-retinol binding protein (RBP) was kindly provided by
C. Hübner (University of Jena, Germany), polyclonal anti-major urinary
protein 1 (MUP1) from Santa Cruz (Heidelberg, Germany), guinea
pig-anti-nephrin from Acris (Herford, Germany), rabbit-anti-MnSOD
from Millipore (Temecula, CA, USA). Horseradish peroxidase (HRP)-
conjugated anti-rabbit-IgG, CY2-conjugated rabbit-anti-guinea
pig-IgG and CY2-conjugated donkey-anti-rabbit-IgG were fromJackson ImmunoResearch Laboratories (West Grove, PA, USA).
ToPro3® was from Invitrogen/Molecular Probes (Carlsbad, CA,
USA) and Texas red wheat germ agglutinin from Vector (Burlingame,
CA, USA).
2.3. RNA extraction, cDNA preparation and real-time PCR
Total ribonucleic acid (RNA) was prepared from mice kidneys
with TRI® Reagent from Applied Biosystems/Ambion (Austin, TX,
USA) followed by phenol–chloroform extraction according to the
manufacturer's instructions. RNA was reverse transcribed into cDNA
using High-Capacity cDNA Reverse Transcription Kit (Life Technolo-
gies/Applied Biosystems, Carlsbad, CA, USA). Quantitative RT-PCR was
performed using Mx3000P™ QPCR System from Agilent Technologies/
Stratagene (Santa Clara, CA, USA). Maxima® Probe qPCR Master Mix
from Thermo Scientiﬁc/Fermentas (Waltham, MA, USA) and TaqMan®
Gene Expression Assays (Life Technologies/Applied Biosystems,
Carlsbad, CA, USA) were used. TaqMan assay ID numbers are listed
in the supplementary methods (Supplementary Table 1). The rela-
tive level of each mRNA was determined using the comparative CT
method [15].
2.4. Western blotting
Membrane protein fractions were extracted by homogenization
of 100 mg of mouse kidney tissue in 500 μl 50 mM Tris–HCl pH 7.4
containing 2 mM EDTA and 2% proteinase inhibitor cocktail (Sigma,
Deisenhofen, Germany) with a 20-gauge needle followed by centri-
fugation at 1000 ×g for 5 min at 4 °C. The postnuclear supernatant
was centrifuged at 100,000 ×g for 30 min at 4 °C, and the pelleted mem-
branes resuspended by addition of 200 μl of 10 mM phosphate-buffered
saline pH 7.4 containing 0.5% Triton X-100 (Sigma) and 2% proteinase in-
hibitor cocktail and subsequent ultrasoniﬁcation. The homogenate was
centrifuged at 100,000 ×g for 30 min at 4 °C, the supernatant collected
and protein concentration calculated with the BioRad protein assay
(Munich, Germany). Membrane protein extracts (250 μg of protein)
were used for Western blotting with anti-OAT1 (0.17 μg/ml) or anti-
MnSOD antibody (1:1 000) and visualized with HRP-conjugated anti-
rabbit IgG (1:5 000) and enhanced chemiluminescence reagents.
Urine aliquots corresponding to an amount of 1 μg creatinine were
used for SDS-PAGE andWestern blotting with anti-Retinol Binding Pro-
tein antibody (1:250) or anti-MUP1 antibody (1:200), and visualized
with HRP-conjugated anti-rabbit IgG (1:5 000) and enhanced chemilu-
minescence reagents.
2.5. Histology and immunohistochemistry in kidneys of Gcdh−/− and
wild-type mice
Whole kidneys were perfused, ﬁxed in 4% buffered formalin for 24 h,
and embedded in parafﬁn (Medim Histotechnologie, Buseck, Germany).
Deparafﬁnized and rehydrated sections (2 μm) were either stained by
the periodic acid-Schiff (PAS) reaction or processed for immunohisto-
chemical stainings. Antigen retrieval was performed by microwave anti-
gen retrieval in citrate buffer, pH 6.1 for 25 min (nephrin) or in DAKO
antigen retrieval buffer pH 9.0 for 15 min at 98 °C in a steam cooker.
After blocking in 5%horse serum (Vector) for 30 min, the tissuewas incu-
bated with primary antibodies (anti-nephrin 1:100; anti-OAT1, 1:200)
in 5% horse serum over night at 4 °C. For double immunoﬂuorescence
microscopy, antibody binding was visualized using afﬁnity puriﬁed
CY2-conjugated secondary antibodies diluted 1:400 in 5% horse serum
for 30 min. ToPro3 (1:2000) was used for nuclear staining and Texas
red-coupled wheat germ agglutinin (1:400) for counterstaining of apical
membranes. Stainings were evaluated under an Axioskop (Zeiss, Jena,
Germany) and photographedwith an AxiocamHRc (Zeiss) or by confocal
microscopy with a LSM 510 meta microscope using the LSM software.
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(Adobe, San Jose, CA, USA).2.6. Electron microscopy
Mice were deeply anesthetized with an intraperitoneal injec-
tion of sodium pentobarbital 100 mg/kg. A ﬁxative solution of 4%Fig. 1.mRNAexpressionof renal transporters. The relativemRNAexpressionofNaC3 and the
organic anion transporters Oat1, Oat2, Rst, and Oatp1a6 was tested in kidney tissues of
wild-type (WT) or Gcdh−/− mice under ND or HPD administered for four days, and com-
pared to each other as indicated. ThemRNA expression of the respective reference condition
(WT or ND) was assigned as 1, indicated by horizontal black lines. Bars indicate relative
mRNA expressions (mean ± SD; RNA of kidney tissues of three mice per group were pre-
pared and measured in triplicates). Signiﬁcance was tested by one-way analysis of variance
followed by least signiﬁcant difference test; *p b 0.05, **p b 0.01.paraformaldehyde and 1% glutaraldehyde in 0.1 M phosphate buff-
er at pH 7.2–7.4 was perfused transcardially. The kidneys of the per-
fused mice were immediately submerged in a solution of the same
ﬁxative and stored overnight. 150 μm thick Vibratom sections were
cut with a vibratome (Leica VT 1000S). The sections were rinsed three
times in 0.1 M sodium cacodylate buffer (pH 7.2–7.4) and osmicated
using 1% osmium tetroxide in cacodylate buffer. Following osmication,
the sections were dehydrated using ascending ethyl alcohol concentra-
tion steps, followed by two rinses in propylene oxide. Inﬁltration of the
embedding medium was performed by immersing the pieces in a 1:1
mixture of propylene oxide and Epon andﬁnally in neat Epon and hard-
ened at 60 °C. Semithin sections (0.5 μm) were prepared for LM
mounted on glass slides and stained for 1 min with 1% toluidine blue.
Ultrathin sections (60 nm)were cut andmounted on copper grids. Sec-
tions were stained using uranyl acetate and lead citrate. Thin sections
were examined and photographed using an EM902 (Zeiss) electron
microscope.2.7. TUNEL staining
In order to detect apoptotic tubular cells in Gcdh−/− mice after the
high protein diet challenge, TUNEL stainings were performed using the
ApopTag Fluorescein in situ apoptosis detection kit (Millipore/Chemicon,
Billerica, MA, USA) according to the manufacturer's instructions. Brieﬂy,
3 μm parafﬁn sections were deparafﬁnized and rehydrated. Antigen re-
trieval was performed using proteinase K (20 μg/ml, Sigma) for 15 min
at RT. Working strength TdT (terminal deoxynucleotidyl transferase)
enzyme was added for 2 h at 37 °C to modify apoptotic DNA fragments
with digoxigenin-labeled nucleotides. Digoxigenin-labels were visualized
usingworking strengthﬂuorescein-conjugated anti digoxigenin antibody.
ToPro3 (1:2 000) was used for nuclear staining. Stainings were evaluated
with a LSM 510 meta microscope (Zeiss, Jena, Germany) using the LSM
software. Sections of wild-type mouse kidneys treated with DNAse
(1 μg/ml, 30 min at 37 °C) were used as apoptose-positive controls.2.8. Albumin and creatinine quantiﬁcation in urine
Urine albumin content was quantiﬁed using a commercially available
ELISA system (Bethyl, Montgomery, TX, USA) according to the
manufacturer's instructions using an ELISA plate reader (BioTek,
EL 808) as described [16]. The urinary albumin concentration was
calculated according to the formula for absorption = (A − D) /
1 + (x / C)B + D), where A and D are values from the standard
curve. Regression values for the standard curve with r-values > 0.9950
indicated accurate measurements. Urinary albumin values were stan-
dardized against urine creatinine values of the same animals. Urine
pH, glucose and creatinine concentrations were determined by routineFig. 2. OAT1 protein expression inmouse kidney. Extracts of kidney tissues (250 μg protein)
derived from42 day-oldwild-type (+/+) orGcdh-deﬁcient (−/−)mice treatedwith ND or
HPD for four dayswere analyzed byOAT1Western blotting (n = 2). Themitochondrial pro-
tein manganese-dependent superoxide dismutase (MnSOD) was used as loading control.
*Unspeciﬁc Oat1-immunoreactive band.
Fig. 3. High expression of OAT1 at basolateral membranes of proximal tubule cells in Gcdh−/−mice. Kidneys were prepared from 42 day-oldwild-type and Gcdh−/− littermates after 4 days of
ND and HPD. Kidney sections (2 μm) of wild-type (A–D) and Gcdh−/− (E–H)mice were analyzed for OAT1 immunoreactivity (green). Apical membranes of proximal tubule cells were labeled
bywheat germagglutinin-Texas red (red). Nuclei are stained by ToPro3 (blue). Bar length: 20 μm(A, C, E, G), and 10 μm(B, D, F, H). L: proximal tubule lumen. Arrows indicate colocalizations of
OAT1 with wheat germ agglutinin-Texas red. Brackets (D, H) mark the thickness of tubule brush border membrane.
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Fig. 4. Time course of mRNA expression of renal transporters during induced metabolic
crises. The Oat2 (A), Rst (B), and Oatp1a6 (C) mRNA expression was analyzed every day
after start of HPD administration to Gcdh−/− mice as compared to wild-type mice on
ND. Dots display mean values of three experiments (each carried out in triplicates,
performed with RNA derived from three different mice per group), or values of single
experiments (carried out in triplicate 1, 1.5, 2 and 3 days after start of HPD), as com-
pared to the respective mRNA level of wild-type mice on ND.
1467B. Thies et al. / Biochimica et Biophysica Acta 1832 (2013) 1463–1472methods in theDepartment of Clinical Chemistry of theUniversityMed-
ical Center Hamburg-Eppendorf.
2.9. Silver staining of urine
Urine aliquots corresponding to an amount of 1 μg creatinine were
loaded on SDS-PAGE. Protein staining was performed by silver staining
as described previously [17].
2.10. Data analysis
Data were analyzed using one-way analysis of variance followed by
Least Signiﬁcant Difference Test. Signiﬁcance was accepted at p b 0.05.
SPSS 12.0 software (SPSS, Chicago, IL, USA) was used for calculations.
3. Results
3.1. AlteredmRNA expression of renal transporters in Gcdh−/−mice during
induced metabolic crises
Recently,we have reported on an upregulation ofNaC3mRNAexpres-
sion in kidneys of Gcdh−/− mice under basal conditions in comparison
with wild-typemice [11]. To examine the effect of inducedmetabolic cri-
ses, the renal transcript levels of NaC3, Oat1 and Oat2 (the murine equiv-
alent of hOAT4) were measured after a four day administration of a
normal diet (ND) and a high protein diet (HPD) in 42 day-old wild-type
and Gcdh−/− mice. As controls mRNA expression of Rst and Oatp1a6,
which are organic anion transporters not involved in GA and 3OHGA
translocation, were determined.
In addition to NaC3, the mRNA expression of Oat1 was 2.4-fold
upregulated in the kidney of Gcdh−/− mice under ND as compared to
wild-type mice (Fig. 1A; [11]. The renal expression of Oat2, Rst and
Oatp1a6 did not differ between wild-type and Gcdh−/−mice on ND. The
administration of HPD to wild-type animals increased the mRNA expres-
sion of NaC3 as well as Oat2 3.8- and 4.2-fold, respectively (Fig. 1B),
whereas the expression of the other transporters tested remained
unchanged. In Gcdh−/−mice the HPD resulted in a small but not signiﬁ-
cant increase inNaC3 expression (range 1.1- to 1.9-fold, Fig. 1C), whereas
the expression of Oat1, Oat2, Rst and Oatp1a6 decreased (50, 26, 28, and
13%, respectively) relative to Gcdh−/−mice on the ND (Fig. 1C). To evalu-
ate whether these effects resemble speciﬁc alterations of Gcdh−/− mice
during induced metabolic crises, or rather represent unspeciﬁc ﬁndings
due to administration of HPD alone, the mRNA expressions of trans-
porters inGcdh−/−mice onHPDwere compared directly towild-type an-
imals on HPD (Fig. 1D). These data revealed comparable results (Fig. 1D
versus C), indicating that the observed alterations in transporter mRNA
expression are effects speciﬁcally attributable to the induced metabolic
crisis in Gcdh−/−mice.
3.2. OAT1 protein expression in kidney tissue of Gcdh−/− mice during
induced metabolic crises
To examine whether the altered levels of Oat1-mRNA correlate with
altered OAT1 protein expression, Western blot analyses were performed.
As shown in Fig. 2, in animals on theND the level of OAT1proteinwas sig-
niﬁcantly increased in kidneys of Gcdh−/− mice in comparison to wild-
type animals. The administration of an HPD resulted in a slight increase
of renal OAT1 protein level in wild-type mice, whereas the OAT1 protein
content in kidneys of Gcdh−/−mice was further augmented in compari-
son to a normal diet (Fig. 2).
When the localization of OAT1 was examined by double immunoﬂu-
orescence histochemistry, OAT1 was found at the basolateral membrane
of proximal tubules of wild-type mice as expected on both ND (Fig. 3A,
B), and the HPD (Fig. 3C, D). In contrast, OAT1-immunoreactive staining
intensity was strongly increased in Gcdh−/− mice under ND (Fig. 3E, F),
and further increased by HPD administration in comparison to wild-type littermates (Fig. 3G, H). Additionally, HPD treatment led to a
mislocalization of OAT1 to apical membranes of proximal tubule cells
stained by wheat germ agglutinin (WGA)-Texas red in Gcdh−/− mice
(Fig. 3F, H, arrows). In addition, theWGA-Texas red staining clearly dem-
onstrates a marked thinning of the proximal tubular brush border under
conditions of HPD inGcdh−/−mice (Fig. 3D vs. H, brackets; Supplementa-
ry Fig. 1).3.3. Time course of renal transporter mRNA expression during induced
metabolic crises
To examine whether the observed mRNA downregulation of Oat2
and Rst expressed at the apical membrane of proximal tubule cells
[18,19], and of Oatp1a6 after four days of HPD treatment is an imme-
diate or later response, their mRNA expressions in Gcdh−/− mice
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pression inwild-typemice on ND. The relativemRNA expressions ofOat2
and Oatp1a6 decreased in a linear manner (Fig. 4A and C), whereas the
decrease in Rst transcript level was slightly delayed (Fig. 4B).
3.4. Histologic alterations in kidneys during induced metabolic crises
PAS staining was performed in order to evaluate light microscopic
alterations in kidneys of Gcdh−/− mice in comparison to wild-type
mice under conditions of ND or HPD. Glomeruli appeared normal on
both diets in Gcdh−/− and wild-type mice (Fig. 5A–D). In nephrons, a
signiﬁcant loss of the apical brush border was visible along the convo-
luted and straight parts of the proximal tubules of Gcdh−/− mice on
HPD (Fig. 5D, Supplementary Fig. 2). Proximal tubular cells appeared
vacuolated in some regions (Supplementary Fig. 2), and a negligible
fraction of the tubules were occluded by protein casts. No changes
along the distal tubules or collecting duct tubules could be observed
by light microscopic evaluation (data not shown).
To further evaluate alterations of proximal tubule cells (Fig. 5D),
ultrathin sections of kidneys were prepared and analyzed by electronmi-
croscopy. The ultrastructure of renal proximal tubules from wild-type
mice on ND and HPD, and Gcdh−/− on ND showed no abnormalities
(Fig. 6A–F). In contrast, ultrathin sections derived from Gcdh−/− mice
after 4 days of HPD treatment showed enlarged and electron lucentmito-
chondria in renal proximal tubule cells (Fig. 6G, H). Quantitative analysis
of the size of mitochondria conﬁrmed a signiﬁcant 4-fold enlargement of
mitochondria in HPD-treated Gcdh−/−mice when compared to Gcdh−/−
mice on ND or wild-type animals on either diet (1.57 ± 1.2 μm2 vs.
0.38 ± 0.3 μm2; respectively; p b 0.001; n = 321 wild-type mitochon-
dria, n = 224 Gcdh−/−mitochondria; Supplementary Fig. 3).
To evaluate the glomerular ﬁltration barrier nephrin immunohisto-
chemistry was performed, which demonstrated no abnormalities in
Gcdh−/− mice on either diet, indicating that podocyte foot processesFig. 5. PAS staining of kidneys of Gcdh−/− and wild-type mice. PAS stainings of 2 μm kidney
istration of ND (A, C) and HPD (B, D) were performed. Bar length: 20 μm. Note brush bordand podocyte morphology were not altered in any of the conditions test-
ed (Supplementary Fig. 4). In addition, no signiﬁcant tubular apoptosis
was detected in Gcdh−/−mice on ND or after administration of HPD
in comparison to wild-type control mice, examined by TUNEL assay
(Supplementary Fig. 5).
3.5. Urinary protein excretion in wild-type and Gcdh−/− mice
To test whether the alterations in transporter expression and localiza-
tion in kidneys of Gcdh−/−mice on HPD are accompanied by functional
abnormalities, the protein composition of urine from wild-type and
Gcdh−/−mice during the four-day administration of ND andHPDwas an-
alyzed. Wild-type mice displayed a uniform excretion of an 18 kDa pro-
tein on ND as well as during administration of HPD for 4 days (Fig. 7).
In urines of Gcdh−/− mice on ND or HPD the excretion of the
18 kDa polypeptide was strongly decreased. In addition, Gcdh−/−
mice on HPD showed a low molecular weight proteinuria from the
ﬁrst day of HPD treatment. Western blot analyses showed that the
18 kDa polypeptide corresponded to mouse major urinary protein 1
(MUP1) and conﬁrmed the decrease in MUP1 excretion in Gcdh−/−
mice as compared to wild-type animals (Supplementary Fig. 6).
Further analyses of urine revealed no differences in the excretion of
retinol binding protein (RBP, data not shown), or albumin (Supplementa-
ry Fig. 7). There were also no differences in urine pH (pH 5.6 ± 0.5 and
5.4 ± 0.5, respectively) or glucose content (data not shown) between
wild-type and Gcdh−/−mice on the HPD.
4. Discussion
Herewe have shown that ametabolic crisis induced by a high protein
diet in Gcdh−/− mice leads to i) altered expression of NaC3 and OAT1
transporters mediating the translocation of the pathologic metabolites
GA and 3OHGA, ii) mislocalization of OAT1 to apical membranes ofsections of 42 day-old wild-type (A, B) and Gcdh−/−mice (C, D) after four-day admin-
er membrane thinning in Gcdh−/− mice treated with HPD (D).
Fig. 6. Electron microscopic evaluation of kidney proximal tubules. Ultrathin kidney sections (60 nm) from wild-type (A–D) and Gcdh−/− (E–H) mice kept on ND or four days on HPD
were examined by electronmicroscopy. Magniﬁcation: ×7000 (A, C, E, G; bar length 2 μm), ×12,000 (B, D, F, H; bar length 1 μm). Notably, electronmicrographs revealed an enlargement
as well as a reduced electron density of mitochondria in kidney proximal tubule cells from HPD-treated Gcdh−/−mice (G, H) as compared to the other conditions tested.
1469B. Thies et al. / Biochimica et Biophysica Acta 1832 (2013) 1463–1472renal proximal tubule cells, and iii) histomorphological changes in the
kidney contributing to functional tubulopathy during induced metabolic
crises in Gcdh−/−mice.Previously, we identiﬁed NaC3, OAT1 and OAT4 as being capable of
transporting GA and 3OHGA in a concerted action from the basolateral
to the apical site of renal proximal tubule cells, thus facilitating their
Fig. 7. Protein excretion into urine of HPD-treated mice. 24 h urine was collected from Gcdh-deﬁcient (−/−) and wild-type (+/+) mice during ND and HPD administered for four
days. Aliquots (1 μg creatinine) were separated by SDS-PAGE and visualized by silver staining. The positions of molecular mass marker proteins (in kDa) are indicated.
1470 B. Thies et al. / Biochimica et Biophysica Acta 1832 (2013) 1463–1472urinary excretion [11,12,20]. Here we found that in addition toNaC3 [11],
the Oat1mRNA level was signiﬁcantly increased in kidneys of 42 day-old
Gcdh−/−mice. OAT1 is capable of transporting GA and 3OHGAwith high
afﬁnity across membranes [12]. However, NaC3 binds GA and 3OHGA
with low afﬁnity [11], and is believed to primarily mediate the uptake
of α-ketoglutarate at the basolateral membrane [21], which is required
indirectly for the secretion of a variety of organic anions [22]. The in-
creased expression of both NaC3 and OAT1 in kidneys of Gcdh−/− mice
appears to be an adaptive response to the increased plasma levels of GA
and 3OHGA [10]. OAT2, themurine homolog of humanOAT4 that is local-
ized at the apical membrane and involved in excretion of organic anions,Fig. 8. Model of proximal tubule cell alterations during induced metabolic crises in Gcdh−/−mice
membrane. NaC3 mediates the sodium-dependent inﬂux of dicarboxylates such as α-ketoglutara
the TCA cycle [22,31]. (B) Gcdh−/−mice under basal conditions on a normal diet (ND) show an u
centrations of the pathologic metabolites GA and 3OHGA. NaC3 and OAT1 are capable to media
ortholog to human OAT4 is a likely candidate for the excretion of GA and 3OHGA into urine at th
by a high protein diet (HPD), blood concentrations of GA and 3OHGA show a further increase [10
diated by increased numbers of NaC3 and OAT1. In addition to increased basolateral uptake, decrea
metabolites. GA and 3OHGAmay contribute to proximal tubule cell injury by at least twomechan
diates viaOAT1 andNaC3 into the cells, subsequently 2. affecting respiratory chain (RC) activity and
The associated structural and functional changes (decrease in proximal tubule brush border memb
renal proximal tubule cell in Gcdh−/−mice. The role of OAT1 dislocalized to the apical membraneaswell as two unrelated transporters were not altered in their expression
(Fig. 8A, B).
Upon high protein diet (HPD) young Gcdh−/− mice develop severe
catabolic crises within four days of treatment, resembling ﬁndings in
GA1 patients [9,10]. The crisis is accompanied by a further increase of
GA and 3OHGA in body ﬂuids and tissues of Gcdh−/− mice, leading to
death within 4–5 days [10]. When Gcdh−/− mice exposed to HPD were
intravenously injected with [3H]-3OHGA, high amounts of radioactivity
were found in kidneys [10], suggesting that under conditions of HPD
either the uptake of 3OHGA into kidney cells is increased, the excretion
rate is decreased, or both occur simultaneously. The mRNA levels,. (A) In wild-type mice, OAT1 and NaC3 are expressed at the basolateral, OAT2 at the apical
te (αKG) and tricarboxylic acid cycle (TCA) intermediates used as anaplerotic substrates for
pregulation of NaC3 and OAT1, which may represent an adaptive response to increased con-
te the basolateral uptake of GA and 3OHGA into proximal tubule cells. OAT2 as the murine
e apical membrane [12]. (C) Under conditions of metabolic crises in Gcdh−/−mice induced
], leading to an elevated basolateral uptake of GA and 3OHGA into proximal tubule cells me-
sed apical OAT2 expressionmight contribute to the intracellular accumulation of GA/3OHGA
isms: 1. GA and 3OHGAmay competitively inhibit the uptake ofαKG and TCA cycle interme-
mitochondrial production of energy-rich substrates accompanied bymitochondrial swelling.
rane thickness, and lowmolecular weight proteinuria)may contribute to acute injury of the
remains unclear.
1471B. Thies et al. / Biochimica et Biophysica Acta 1832 (2013) 1463–1472however, of the basolaterally localized Oat1 and the apical Oat2were ob-
served to be decreased by 50 and 74%, respectively, in kidneys ofGcdh−/−
mice onHPD. The transcriptional regulation of OAT1, OAT3, and OAT4
in kidneys is coordinated by hepatocyte nuclear factor (HNF) 1α,
HNF1β, and HNF4α [23–25]. The signal cascade initiating the
transactivation of OATs by HNFs under HPD remains to be studied.
The OAT1 protein expression, however, was further augmented in
kidneys of Gcdh−/− mice in comparison to animals treated with
ND, which may explain the elevated uptake of [3H]-3OHGA into kid-
ney cells of HPD-treated Gcdh−/−mice [10]. On the other hand, HPD
led to a mislocalization of OAT1 to apical membranes of proximal tu-
bule cells, which might impair the turnover resulting in a decreased
degradation rate of the OAT1 protein (Fig. 8C). The polarized distribu-
tion and function of OATs in proximal tubule cells are mediated by in-
teraction with PDZ (PSD-95/Dlg/ZO-1) domain-containing proteins,
such as NHERF-1 and -3 [26]. Thus, NHERF-1 is responsible for apical
targeting and trafﬁcking and enhances OAT4-mediated transport activ-
ity [27], whereas OAT1 contains a NHERF-3 consensus binding motif
(QQL) in its C-terminal cytosolic domainmediating its basolateral local-
ization. In response to changes in intracellular second messenger con-
centrations and subsequent phosphorylation of NHERFs by protein
kinases C and A [28,29], OATs are either inserted into or retrieved
from the cell surface. The signaling processes resulting in dislocalization
of OAT1 to apical membranes of proximal tubule cells in HPD-treated
Gcdh−/−mice will be investigated in future studies.
The HPD-inducedmetabolic crises led to both structural and function-
al changes in the kidney, including a decrease in proximal tubule brush
bordermembrane thickness,mitochondrial swelling, and a lowmolecular
weight proteinuria in Gcdh−/−mice suggesting the presence of an acute
tubular injury. The mechanism(s) via which accumulating GA and
3OHGA metabolites affect proximal tubule cells remain unclear. It has
been suggested that in addition to excitotoxicity and oxidative stress,
GA and 3OHGAmay impair indirectly the mitochondrial energy metabo-
lism [30] by e.g. interference with transport processes essential for the
maintenance of cellular functions. Thus, similarly to the inhibition of the
dicarboxylate transporter-mediated anaplerotic supply of tricarboxylic
acid cycle intermediates from astrocytes to neurons by GA and 3OHGA
[7], the metabolites may contribute to mitochondrial energy depletion
and cell death in proximal tubule cells. The decreased excretion into
the urine of the nutrient and energy-controlled MUP1 in Gcdh−/−
mice, both under conditions of ND and HPD, further supported the
pathomechanistic concept of primary mitochondrial dysfunction in
GA1, encompassing proximal tubular cells.
Taken together, the present data provide evidence of dysregulated
expression of transporters involved in the translocation of the cytotoxic
metabolites GA and 3OHGA in proximal tubule cells during metabolic
crises in Gcdh−/− mice. The altered expression pattern of these trans-
porters and resulting changes in cytotoxic metabolite levels may con-
tribute to mitochondrial dysfunction and subsequent acute tubular
injury in the GA1mousemodel. Future studieswill be required to deter-
mine whether similar effects on proximal tubule cell function occur in
human patients with GA1.
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